Health

Hot Topics in Health

Examining the Prescription Drug User Fee Act

Read NCL's testimony to the FDA NCL's Sally Greenberg testified before the FDA recently about the re-authorization of the Prescription Drug User Fee Act, calling on the federal agency to seize this opportunity to critically examine the impact of the program, and make meaningful changes to enhance the safety of drugs in this country.

NCL forum explores biologics pathway

Access to safe and affordable medications has long been a priority of NCL. It is especially important now as consumers increasingly rely on pharmaceutical and biotechnology products to enhance and prolong their lives. Due both to increased utilization and product costs, the amount consumers spend on these therapeutics has increased significantly in the last decade.